Loading...
NPI 1073599478 · Seattle, WA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America is a clinical medical laboratory provider located in Seattle, Washington. This profile covers 497 Medicare and 449 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America |
| Address | 550 17th Ave, Suite 300 |
| City | Seattle |
| State | WA |
| ZIP | 98122 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | December 16, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $186.7M |
| Medicare | $25M |
LABORATORY CORPORATION OF AMERICA presents a classic clinical laboratory service mix: high-volume specimen collection (36415) plus routine chemistry and hematology panels (80053, 80061, 85025, 80048) dominate Medicare billing, while Medicaid volume also includes large molecular and infectious disease testing (U0003, 87491, 87591) and specialized genomic screening (81420). The code mix points to centralized, high-throughput lab processing rather than point-of-care clinical services.
Revenue concentration on Medicare is significant: this provider reports $25M in total Medicare revenue and its top 3 Medicare codes account for 36.9% of that Medicare revenue, driven primarily by 36415, 80053, and 80061. That concentration shows routine collection plus core metabolic/lipid testing are the principal Medicare revenue drivers.
On Medicaid the provider reports $186.7M in total revenue and its top 3 Medicaid codes account for 28.1% of Medicaid revenue, led by U0003, 80050, and 87491. Medicaid billing is therefore more diversified across a larger absolute dollar base but still concentrated around high-volume infectious disease, screening panels, and general health panels.
Payer mix is heavily Medicaid-weighted: Medicaid revenue ($186.7M) is an order of magnitude larger than Medicare revenue ($25M), indicating the provider operates with a Medicaid-dominant book of business and is not effectively single-payer. Operational priorities, contracting, and capacity planning are likely driven by Medicaid volumes and reimbursement patterns.
Competitive standing on Medicare is unusually large for many routine tests: multiple top Medicare codes are reported in the 100th percentile nationally as extreme outliers (for example 36415 ranks #19 of 86467 and 80053 ranks #27 of 26416), indicating the provider is a major national volume leader for specimen collection and common lab panels. These rankings signal national-scale throughput on core laboratory services rather than modest local participation.
Competitive standing within Washington Medicaid is dominant for many codes: the provider ranks #1 in-state on numerous high-revenue Medicaid codes such as 80050, 80061, 80053, 84443 and others, and ranks #2 in-state for high-volume pandemic testing U0003. State-level ranks at the 100th percentile for many tests indicate this entity is a primary in-state lab hub for Washington Medicaid.
Most high-volume codes are labeled ‘extreme outlier’ or ‘notably above typical’ in the supplied comparisons, reflecting volumes far above typical peers (examples include 80061 and 80053 on both payers). A small number of codes are identified as ‘typical, unremarkable’ or lower percentile (for example Medicare 86480 at the 96th percentile and Medicaid 80307 at the 94th percentile), showing that while the provider is extreme on many routine and molecular tests, not every test-line is an outlier.
The provider has long tenure in the NPI registry (NPI enumerated 2005-12-16 (~21 years ago)), which, combined with very large Medicaid and national Medicare volumes, supports an interpretation of established, sustained laboratory operations and capacity to manage high-throughput testing over time.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
497 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 313,710 | $10 | $2.5M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 213,940 | $10 | $2.1M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 141,260 | $10 | $1.8M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 114,660 | $20 | $1.8M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 176,710 | $10 | $1.4M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 100,020 | $10 | $1M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 28,920 | $30 | $838.5K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 17,600 | $40 | $704K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 14,850 | $40 | $519.8K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 28,840 | $20 | $519.1K |
Showing 1–10 of 497
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 497 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
497 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81479 | 3 | 10 | 90 | $5,800 | $3.7M |
| 81490 | 1 | 10 | 190 | $820 | $158.2K |
| G0483 | 14 | 20 | 90 | $240 | $69.8K |
| 83521 | 1 | 10 | 1,460 | $20 | $44.4K |
| G0480 | 3 | 40 | 50 | $110 | $40.5K |
| 86480 | 1 | 10 | 80 | $60 | $39.5K |
| 88305 | 1 | 340 | 530 | $40 | $39.4K |
| 84402 | 1 | 10 | 760 | $20 | $37.5K |
| U0003 | 6 | 20 | 30 | $70 | $37.2K |
| G0482 | 34 | 60 | 50 | $190 | $34.8K |
Showing 1–10 of 497
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
449 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 188,980 | $70 | $13.4M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 434,730 | $30 | $11.3M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 353,270 | $30 | $9.5M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 353,000 | $30 | $9.2M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 923,510 | $10 | $8.3M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 996,120 | $10 | $7M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 18,020 | $370 | $6.7M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 564,940 | $10 | $6.2M |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 356,440 | $20 | $6.1M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 753,040 | $10 | $4.5M |
Showing 1–10 of 449
How this provider's Medicaid billing volume and revenue compare to other Washington providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Washington median
449 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 11 | 20 | 1,010 | $140 | $3M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 9 | 30 | 660 | $100 | $1.5M |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 1 | 10 | 130 | $370 | $1.3M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 2 | 100 | 1,940 | $70 | $1M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 11 | 170 | 2,120 | $40 | $779.1K |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 1 | 10 | 1,490 | $50 | $707.8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 6 | 90 | 1,760 | $50 | $601.4K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 16 | 20 | 1,110 | $130 | $509.9K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 2 | 120 | 2,040 | $30 | $464.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 2 | 120 | 2,020 | $30 | $441.1K |
Showing 1–10 of 449
Other providers in the same ZIP code as Laboratory Corporation Of America, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.